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Abstract
Background: Assessment of the availability of essential medicines, in rural areas of countries with free state health
care system, is scarce. Dependence on essential medicines among the population in rural sector is considered to be
high. Assessing the availability of essential medicines in selected state owned primary and secondary health care
institutions of a rural district will help to identify areas where improvement is needed.
Methods: A descriptive cross sectional study, covering selected five primary and one secondary care institutions of
a rural Sri Lankan district, was conducted. The national list of essential medicines, Sri Lanka was used as the check
list and the guidelines of the WHO–Health Action International were adapted.
Results: The secondary care institution recorded an overall availability of 71%, whereas the average overall
availability of the primary care institutions was 56%. Central dispensaries recorded the lowest availability. Lack of
availability of medicines needed for the management of chronic kidney disease, snake bite and poisoning was
noted.
Conclusions: Availability of essential medicines in most of the primary and the secondary care institutions were
fairly high. Deficiency in medicines needed for the management of emergencies was noted. A need based annual
estimate of medicines based on an essential medicine list is suggested.
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Background
Access to medicine is an universal human right, and
availability of medicine is a worldwide problem. Accord-
ing to the World Health Organization (WHO), “Essen-
tial medicines are those that satisfy the priority health
care needs of the population. Essential medicines are
intended to be available within the context of functioning
health systems at all times in adequate amounts, in the
appropriate dosage forms, with assured quality and ad-
equate information, and at a price the individual and
the community can afford” [1].
Essential medicines are not available to 33% of world
population and 50% of people in poorest countries of
Africa and Asia [2]. In 2008 a study carried out in 36 de-
veloping and middle-income countries reported 29–54%
availability of generic medicines in public sector, where
Africa recorded the lowest and America the highest [3].
The availability of 15 generic medicines ranged from
10% in Yemen to 79% in Mongolia. All regions showed a
lower mean availability in the public sector in compari-
son to the private sector. In another study availability of
essential medicines for chronic diseases was less than
7.5% in four low and middle income countries but was
28% in Sri Lanka (SL) [4]. Generic medicines were avail-
able and affordable according to a survey carried out
over 6 year period in retail pharmacies (semi-
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government and private) of SL [5]. The 2013 SL national
survey showed a “fairly high” (50–80%) availability of se-
lected essential medicines for non-communicable dis-
eases (NCD) in both the private and public sectors [6].
However, another SL study revealed that the availability
of key essential medicines for children was “low” (30–
49%) in public hospitals [7].
SL’s health indicators are comparable with developed
countries of Asia and in 2013 SL’s total expenditure on
health was 3.2% of the gross domestic product [8, 9]. Its
allopathic health system consist a universal free (non-fee
levying) government sector and a fee levying private sec-
tor. There are four levels of health care institutions in
the country. The primary care institutions are district
hospitals (DH), peripheral units (PU), rural hospitals
(RH) and central dispensaries (CD). District general hos-
pitals and base hospitals (BH) are secondary care institu-
tions [10].
Previous national surveys have assessed the availability
of essential medicines in SL. Published national surveys
have de-identified locations in the surveys. Hence we are
unable to comment on the urban–rural differences in
availability of the essential medicines [5–7]. An abstract
published in 2015 revealed Anuradhapura, a rural dis-
trict of SL, as the district with highest availability (78%)
for drugs used in NCD [11]. To our knowledge studies
focusing on availability of drugs in rural districts of SL
are scarce. The aim of our study was to assess the avail-
ability of essential medicines in selected public health
care institutions of a district in rural SL.
Methods
A descriptive cross sectional study was conducted dur-
ing the first week of August 2016.
Study setting
The study was conducted in Anuradhapura district of SL
where 95% of households are rural [12]. Agriculture is
the main employment for 55% of the population [13].
Unemployment rate is 3.1% [13]. The mean monthly
household income of the district is 241 USD, compared
to 312 USD for the country [14]. These reasons make
the free public health care service as the first choice of
the people.
One institution each from the following levels of
health care were selected conveniently and visited once
for data collection: base hospital, district hospital, per-
ipheral unit, rural hospital and two central dispensaries.
The second central dispensary was selected according to
WHO–Health Action International (HAI) guidelines. It
recommends to survey another institution of the same
level if the availability of essential medicine is less than
50% at the first surveyed institution [15]. Identities of all
the above institutions were kept confidential.
Instrument
Availability of essential medicines was checked using the
national list of essential medicines, SL [16]. The first edi-
tion was published in 1958 and the fifth in 2014. Clinical
needs, disease prevalence, evidence of efficacy, safety
and comparative cost-effectiveness are considered by the
selection committee in selecting the essential medicines.
The list has 29 major categories of drugs. Out of which
only 28 were relevant to the primary and secondary care
institutions. Under each category there is a core list and
in some a complementary list. The core list includes “a
list of minimum medicine needs for a basic healthcare
system listing the most efficacious, safe and cost‐effect-
ive medicines for priority conditions” [16]. The comple-
mentary list includes “essential medicines for priority
diseases, for which specialized diagnostic or monitoring
facilities, and/or specialist medical care, and/or specialist
training are needed” [16]. The drug information includes
the international non-proprietary name of the active
moiety, dosage forms, strengths and the level of care at
which the drug should be available E.g. Paracetamol tab-
let: 500 mg (primary, secondary, tertiary and specialist
hospitals). This list closely follows the WHO model list
of essential medicines [17] with modifications according
to the needs of SL.
Data collection, analysis and description of data
Permission was obtained from the regional director of
health services and the relevant heads of the institutions.
Availability of essential medicines was checked from the
drug stores and the pharmacies of the institutions, using
the national list of essential medicines, SL by trained
MBBS qualified doctors. According to the WHO–HAI
method the specific dose and form was surveyed for
availability [15]. As with previous studies the availability
of the selected medicine was considered regardless of
whether it is innovator, generic or branded generic [4,
6]. A medicine was considered as available only if the
data collectors physically saw it [15], drug not being ex-
pired and being suitable for use. Data was analyzed using
Microsoft excel. Descriptive statistics were used to de-
scribe data. Drug availability was described according to
earlier national and international surveys; <30%: very
low, 30–49%: low, 50–80%: fairly high and >80%: high
[6, 18]. Each dosage form of a particular medicine was
considered as separate items. Medicines available in sev-
eral core or complementary lists of the national list of
essential medicines are counted only once [16].
Deviations in methodology from the WHO–HAI
recommendations
According to our objective we plan to find out the avail-
ability of essential medicines in selected public health
care institutions of a rural SL district using the national
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list of essential medicines, SL. Therefore we differed in
the following steps:
 Only availability of drugs was checked and data on
pricing was not collected as medicines are dispensed
free of charge in state sector [6].
 Only institutions of public primary and secondary
care were selected as our objective was to find the
availability of essential medicines only in these
institutions.
 All drugs included in the national list of essential
medicines, SL were checked. We did not restrict the
survey to 50 selected medicines as recommended by
the WHO-HAI.
 Institutions were selected conveniently rather than
randomly. Essential medicines are supposed to be
“available within the context of functioning health
systems at all times”. The aim of the study was to
assess the availability of essential medicines in
selected public health care institutions of a district
in rural Sri Lanka. We do not intend to generalize
the data but would only want to highlight the
deficiencies in the availability of essential medicines
in those selected institutions.
Results
Numbers for inward, deliveries and out patients for each
of the selected institution for the year 2015 were re-
trieved from the regional director of health service office
(Table 1). Availability of essential medicines in BH, DH,
PU, RH and CD-1 were 71, 81, 64, 58 and 32% respect-
ively. As the total availability at CD-1 was less than 50%,
second central dispensary (CD-2) was surveyed as
planned. Availability of essential medicines in CD-2 was
also less than 50% (47%). Availability of individual essen-
tial medicines is given as an Additional file 1.
Primary care institutions
The highest availability of essential medicine was seen in
DH (81%), a primary care institution, the next best was
BH (71%), a secondary care institution. Availability was
“fairly high” in PU and RH, whereas it was “low” in both
the CDs.
DH showed 100% availability in analgesics, anti-
allergics, diuretics, immunologicals, genitourinary medi-
cines, psycho-therapeutic medicines, respiratory medi-
cines, vitamins & minerals and neonatal care medicines.
However it recorded “low” or “very low” availability in
medicines affecting the blood (33%), diagnostic agents
(0%) and ophthalmological preparations (33%) (Table 2).
PU showed 100% availability in diuretics and solutions
correcting electrolytes. “Low” or “very low” availability at
PU was recorded with anticonvulsants (46%), medicines
affecting the blood (33%), dermatological preparations
(44%), diagnostic agents (0%), immunologicals (0%),
ophthalmological preparations (0%), ENT medicines
(22%) and medicines for neonatal care (0%) (Table 2).
RH showed 100% availability in diuretics only, whereas
both the CDs failed to show 100% availability in any of
the major categories of essential medicines (Table 2).
Diagnostic agent (tropicamide eye drops) was not avail-
able at any of the primary care institutions. Immuno-
logical (anti-venom serum) and medicines for neonatal
care (chlorhexidine for umbillical cord) were only avail-
able at DH. Anticonvulsants were not available in both
the CDs, whereas CD-2 failed to have any of the anti-
dotes or other substances used for poisoning (Table 2).
Secondary care institution
BH, the only secondary care institution of the survey,
had an overall availability of 71%. It had shown 100%
availability in anaesthetics, anti-allergics, blood products,
antiseptics, diuretics, immunologicals, muscle relaxants,
genitourinary medicines, solutions correcting electro-
lytes and medicines for neonatal care. “Low” or “very
low” availability was seen in anti-parkinsonism medi-
cines (25%), dermatological preparations (33%), diagnos-
tic agents (0%), ophthalmological preparations (0%) and
ENT medicines (44%) (Table 2).
Comparison of availability of essential medicines between
primary and secondary care institutions
BH has a higher overall availability (71%) than the aver-
age overall availability of all primary care institutions
(56%). BH also had most number of drugs (179 vs DH -
134, PU - 105, RH - 96, CD-1 - 52, CD-2 - 78). Second-
ary care institution showed higher availability in 18
major categories compared to the primary care institu-
tions. However, secondary care institution has recorded
lower availability in analgesics, anti-infectives, dermato-
logical preparations, ophthalmological preparations and
vitamins and minerals (Table 2).
The secondary care institution failed to have any oph-
thalmological preparations but 4 out of the 5 primary
care institutions (DH, RH, CD - 1, CD - 2) have had
Table 1 Number of patients for the year 2015 in the selected
institutions of Anuradhapura Tables
Institution Inward Outpatient Deliveries
BH 35,207 238,235 3,219
DH 10,548 170,743 95
PU 4,191 78,714 52
RH 5,352 65,603 40
CD-1 NA 15,448 NA
CD-2 NA 18,858 NA
BH Base Hospital, DH District Hospital, PU Peripheral Unit, RH Rural Hospital,
CD Central Dispensary
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Table 2 Availability of essential medicines (by major category) Anuradhapura, 2016









SCI (%)DH PU RH CD-1 CD-2
1 Anaesthetics 4 3 (75) 3 (75) 2 (50) 1 (25) 2 (50) 2.2 (55) 17 17 (100)
2 Analgesics, antipyretics,
non-steroidal anti-inflammatory
medicines, medicines used to
treat gout and disease modifying
agents in rheumatoid disorders
6 6 (100) 5 (83) 4 (67) 3 (50) 4 (67) 4.4 (73) 12 8 (67)
3 Anti-allergics and medicines used in
anaphylaxis
8 8 (100) 7 (88) 7 (88) 7 (88) 6 (75) 7 (88) 8 8 (100)
4 Antidotes and other substance
used in poisonings
6 3 (50) 3 (50) 2 (33) 1 (17) 0 1.8 (30) 9 8 (89)
5 Anticonvulsants/anti-epileptics 11 9 (82) 5 (46) 6 (55) 0 0 4 (36) 12 6 (50)
6 Anti-infective medicines 24 20 (83) 19 (79) 16 (67) 11 (46) 17 (71) 16.6 (69) 47 32 (68)
7 Anti-migraine medicines 7 6 (86) 5 (71) 4 (57) 5 (71) 3 (43) 4.6 (66) 7 6 (86)
8 Anti-neoplastic, immunosuppressive
and medicines used in palliative care
N/A N/A N/A N/A N/A N/A N/A 5 3 (60)
9 Anti-parkinsonism medicines N/A N/A N/A N/A N/A N/A N/A 4 1 (25)
10 Medicines affecting the blood 6 2 (33) 2 (33) 2 (33) 1 (17) 2 (33) 1.8 (30) 8 4 (50)
11 Blood products and plasma
substitutes
N/A N/A N/A N/A N/A N/A N/A 1 1 (100)
12 Cardiovascular medicines 26 24 (92) 21 (81) 21 (81) 9 (35) 16 (62) 18.2 (70) 27 24 (89)
13 Dermatological medicines (topical) 18 14 (78) 8 (44) 6 (33) 4 (22) 5 (28) 7.4 (41) 24 8 (33)
14 Diagnostic agents 1 0 0 0 0 0 0 (0) 1 0 (0)
15 Disinfectants and antiseptics 6 5 (83) 3 (50) 4 (67) 2 (33) 3 (50) 3.4 (57) 6 6 (100)
16 Diuretics 4 4 (100) 4 (100) 4 (100) 1 (25) 3 (75) 3.2 (80) 5 5 (100)
17 Gastrointestinal medicines 10 8 (80) 8 (80) 9 (90) 5 (50) 5 (50) 7 (70) 15 12 (80)
18 Hormones, other endocrine
medicines and contraceptives
9 8 (89) 7 (78) 7 (78) 4 (44) 6 (67) 6.4 (71) 11 8 (73)
19 Immunologicals 1 1 (100) 0 0 0 0 0.2 (20) 3 3 (100)
20 Muscle relaxant (Peripherally acting)
and cholinesterase inhibitors
N/A N/A N/A N/A N/A N/A N/A 2 2 (100)
21 Ophthalmological preparations 3 1 (33) 0 1 (33) 1 (33) 1 (33) 0.8 (27) 3 0 (0)
22 Medicines acting on the
genitourinary tract
5 5 (100) 4 (80) 4 (80) 1 (20) 1 (20) 3 (60) 5 5 (100)
23 Psychotherapeutic medicines 7 7 (100) 6 (86) 4 (57) 1 (14) 2 (29) 4 (57) 13 10 (77)
24 Medicines acting on the
respiratory tract
10 10 (100) 8 (80) 6 (60) 2 (20) 9 (90) 7 (70) 10 9 (90)




7 6 (86) 7 (100) 6 (86) 3 (43) 4 (57) 5.2 (74) 10 10 (100)
26 Vitamins and minerals 2 2 (100) 1 (50) 1 (50) 1 (50) 1 (50) 1.2 (60) 4 2 (50)
27 Medicines acting on the ear, nose
and oropharynx
9 5 (56) 2 (22) 2 (22) 3 (33) 3 (33) 3 (33) 9 4 (44)
28 Specific medicines for neonatal care 1 1 (100) 0 0 0 0 0.2 (20) 2 2 (100)
Total (%) 165 134 (81) 105 (64) 96 (58) 52 (32) 78 (47) 112.6 (56) 251 179 (71)
Duplication of medicines, in multiple categories of the national list of essential medicines, Sri Lanka (2013–2014), was left out of the calculation of availability (%).
N/A - These categories of the national list of essential medicines, Sri Lanka (2013–2014), are not applicable for primary care institutions. PCI Primary care
institution, SCI Secondary care institution, BH Base Hospital, DH District Hospital, PU Peripheral Unit, RH Rural Hospital, CD Central Dispensary
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ciprofloxacin eye drops. Medicines acting in nose (beta-
methasone nasal drop, silver nitrate crystals) were not
found in any of the institutions selected for the study.
Out of all institutions only DH had povidone iodine
mouth-wash. Aqueous cream and emulsifying ointment
were found only in DH, even the secondary care institu-
tion failed to have it. Availability of anticonvulsants was
50% at the secondary care institution compared to the
mean availability of 36% at the primary care institutions
(Fig. 1). Availability of cardiovascular medicines was 89%
at the secondary care institution compared to the mean
availability of 70% at the primary care institutions
(Fig. 2).
Availability of medicines used in the management of
chronic kidney disease
Essential medicines involved in the management of
chronic kidney disease were ferrous salt, iron sucrose,
erythropoietin, vitamin D3 + calcium carbonate and cal-
citriol [19].
Erythropoietin and calcitriol are not expected to be
available in primary or secondary care institutions. Rest
was expected to be available at all levels of care. The sec-
ondary care institution (BH) failed to have ferrous
sulphate tablets used in the management of iron defi-
ciency anaemia. In comparison 4 out of 5 primary care
institutions (DH, PU, RH, CD-2) have had ferrous
sulphate tablets. Intravenous iron preparation (iron su-
crose) was not found in any of the institutions. Vitamin
D3 + calcium carbonate was found only in DH.
Anti-hypertensive medicines expected to be available
at primary and secondary care levels were atenolol, enal-
april, hydrochlorothiazide, methyldopa and nifedipine.
Except for hydrochlorothiazide and methyldopa, all
other are used in chronic kidney disease. Secondary care
institution had all of them. Methyldopa, used to treat
pregnancy induced hypertension was not available in
PU, CD-1 and CD-2. However, all other anti-
hypertensive medicines were found in all primary care
institutions.
Furosemide, hydrochlorothiazide, mannitol and spir-
onolactone are the diuretics expected to be available at a
secondary care institution. BH had all of them. Out of
the diuretics mentioned above, mannitol is not expected
to be available at primary care institutions. DH, PU and
RH showed 100% availability for diuretics. CD-1 had
only hydrochlorothiazide. CD-2 had all except intraven-
ous furosemide.
Insulin and other anti-diabetic agents
Biphasic insulin, metformin, glibenclamide and tolbuta-
mide were expected to be available in primary care units.
DH, PU and RH had all of those drugs. CD-1 had met-
formin and glibenclamide. CD-2 in addition had tolbuta-
mide. Soluble insulin is expected to be present in
secondary care institutions in addition to the above
medicines. BH had all of them.
Drugs needed in the management of snake bite
Snake anti-venom serum injection was available only at
BH and DH. Adrenaline, hydrocortisone and parenteral
chlorphenamine, which are essential in the management
of anaphylaxis following anti-venom serum administra-
tion, were available in all institutions surveyed.
Antidotes (Table 3)
Secondary care institution is expected to have acti-
vated charcoal, fuller’s earth, acetylcysteine, atropine, flu-
mazenil, DL-methionine, naloxone and pralidoxime; but
fuller’s earth was not available. Activated charcoal, ful-
ler’s earth, atropine, DL-methionine and naloxone were
expected to be available in primary care units. Both CDs
failed to have any of them, except for atropine at CD-1.
PU, RH and DH had activated charcoal and atropine.
These two are essential in the management of organo-
phosphate poisoning [20], the commonest poisoning of
the agricultural areas in SL.
Fig. 1 Percentage availability of different dosage forms of essential anticonvulsants, Anuradhapura, 2016
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Discussion
According to the WHO definition, essential medicines
are expected to be available at all times within a func-
tioning health system [1]. Our study mimicked a patient
visiting a selected institution with a need of a particular
essential medicine. This gives an insight to the availabil-
ity of essential medicines in those selected institutions.
DH is the only health care institution to have a “high”
availability of essential medicine. BH, PU and RH had
“fairly high” availability, whereas both the CDs had “low”
availability. A national survey done in SL revealed an
availability of 36.4% and >50% respectively for primary
and secondary levels of care. The above survey was on
selected essential medicines used in non-communicable
diseases [6]. Another national survey revealed 54, 49 and
45% as the mean availability of key essential medicines
for children in district hospitals, peripheral hospitals and
central dispensaries of SL [7].
Specialist units like ophthalmology, otorhinolaryngol-
ogy, dermatology and neonatology are not available in
primary or secondary care levels. Also number of deliv-
eries is low in primary care institutions. These reasons
Fig. 2 Percentage availability of different dosage forms of essential cardiovascular medicines, Anuradhapura, 2016
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could have contributed to the unavailability of essential
medicines related to these specialities.
More than 70% of availability in BH and DH reflects
larger number of patients utilizing services of these insti-
tutions. Although BH (a secondary care institution) has
lower availability of analgesics and anti-infectives it is a
relative unavailability compared to some primary care
institutions and the essential list. Eight out of 12 analge-
sics and 32 out of 47 anti-infectives are available in BH
compared to 6/6 and 20/24 in DH. Careful analysis of
data (Additional file 1) displays that only some dosage
forms of anti-infectives are not available in BH. Only the
infrequently needed co-trimoxazole and clindamycin are
not available in any form or strength. Among analgesics,
only morphine sulphate tablets are not available in BH.
This may reflect lack of facility for palliative care. Avail-
ability of morphine sulphate tablets in the public sector
was 4% in SL as reported by a study in 2007 [4].
Anuradhapura district is an endemic area for chronic
kidney disease. Lack of availability of medicines related
to chronic kidney disease was noted. Also a national list
of essential medicine cannot address regional variation
of pharmaceutical need and utilization. Certain medi-
cines should be available in all levels of health care for
some parts of the country. Tailoring the essential medi-
cines to suit the needs of a particular region is suggested.
Unavailability of intravenous iron even in a base hospital
may suggest genuine unavailability or lack of utilization.
Intravenous iron is most suitable for treatment of iron
deficiency in chronic kidney disease and rapid treatment
in de novo iron deficiency. Overall, Availability of medi-
cines needed for the management of hypertension and
diabetes was commendable. Availability of anti-diabetics
from a previous national survey in SL was nearly 60% in
public hospitals [6]. The same survey revealed an
availability ranging from 37 to 100% for anti-
hypertensive medicines.
Snake anti-venom serum injection was available only
at DH among the primary care institutions. Considering
the higher prevalence of venomous snake bites in SL dry
zones [21] this situation needs to be rectified immedi-
ately. Higher mortality ratescan be reduced to a certain
extent by preventing unnecessary delay in starting the
anti-venom serum. This situation is despite the fact that
all institutions had medicines needed for managing ana-
phylactic shock following anti-venom serum administra-
tion. However the efficacy of Indian anti-venom serum
(VINS and BHARAT are used in SL) against SL snake
venom is questionable [22].
Atropine, the antidote for organophosphate was avail-
able in all health care institutions except CD-2. A study
conducted in Anuradhapura has shown that pesticides
were the commonest (1572/3813 - 41% of total admis-
sions due to poisoning) agents for poisoning followed by
pharmaceuticals (21% of total admissions due to poison-
ing) [23]. However the same study also shows that the
pattern of deliberate self-harm is changing with in-
creased use of pharmaceuticals. This mandates availabil-
ity of wider range of antidotes. Unavailability of fuller’s
earth in most institutions may be due to the banning of
the specific poisoning “paraquat” since 2010.
Both the CDs have shown unavailability of certain an-
ticonvulsants and antidotes which are needed for the
management of medical emergencies (Table 3, Fig. 1).
The concept of having four levels of care encourages ini-
tial management and stabilization of an acutely ill pa-
tient at the first contact. Uninterrupted supply of
essential medicines used in emergencies is needed to
achieve this goal.
Chlorhexidine solution for umbillical cord care was
available only at DH among the primary care institu-
tions. According to WHO recommendations “daily
chlorhexidine (7.1% chlorhexidine digluconate aqueous
solution or gel, delivering 4% chlorhexidine) application
to the umbilical cord stump during the first week of life
is recommended for newborns who are born at home in
settings with high neonatal mortality (30 or more neo-
natal deaths per 1000 live births). Clean, dry cord care is
recommended for newborns born in health facilities and
at home in low neonatal mortality settings. Use of chlor-
hexidine in these situations may be considered only to
replace application of a harmful traditional substance,
such as cow dung, to the cord stump” [24]. Neonatal
mortality in Anuradhapura is 24 neonatal deaths per
1000 live births according to the latest available data
[25]. Institutional delivery rate in SL is more than 98%
[26]. The above facts justify the non-usage of chlorhexi-
dine and may have been the reason for unavailability.
Also when there are no deliveries or neonatal care in
Table 3 Availability of essential antidotes at selected primary
and secondary health care institutions of Anuradhapura, 2016
Antidote Institutions
BH DH PU RH CD-1 CD-2
Non-specific antidotes
Charcoal (Activated) P P P P A A
Fuller’s earth A P P A A A
Specific antidotes
Acetylcysteine P NA NA NA NA NA
Atropine P P P P P A
Flumazenil P NA NA NA NA NA
DL-methionine P A A A A A
Naloxone P A A A A A
Pralidoxime P NA NA NA NA NA
BH Base Hospital, DH District Hospital, PU Peripheral Unit, RH Rural Hospital,
CD Central Dispensary, P Present, A Absent, NA Not applicable
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certain hospitals (CD-1 and CD-2), medicines related to
pregnancy (such as methyldopa in pregnancy induced
hypertension) and neonatal care (such as chlorhexidine
in umbilical cord care) may not be needed.
Tropicamide eye drops are not available in any of the sur-
veyed institutions. They are being used to dilate the pupils
for examination of retina [27]. Retinopathy survey in dia-
betes seems to be absent in any of the surveyed institutions.
The national list of essential medicines was written exclu-
sively by experts based at Colombo, an urban capital district
of SL. “Experts” may not be available from the rural areas.
However, inputs from prescribers working in rural areas
may enhance the list of essential medicines and make it
more relevant for prescribers in rural areas. Also having a
separate list of essential medicines, for primary care institu-
tions which do not have inward facilities, is suggested.
The concept of “essential medicines” is yet to be
followed by the individual heads of health care institu-
tions. Unavailability of certain medicines may be due to
non-utilization of those medicines by prescribers. Medi-
cines are supplied purely on the annual estimates pre-
pared by the relevant institutions based on usage in the
previous year. This would predict the quantity needed
for the following year but will fail in making available all
varieties of the essential medicines. Continuous medical
education is needed to enlighten prescribing doctors on
the importance of utilizing medicines available in the na-
tional list of essential medicines.
Regardless of all these short coming SL has achieved
health indices comparable to developed countries [8]
and many nationwide studies have also shown a “fairly
high” availability of essential medicines in SL [4, 6]
which was supported by this survey too.
Conclusions
Overall availability of essential medicines at the selected
institutions was fairly high. It was high at BH, a primary
care institution, and low at both the CDs. There is con-
cern in the availability of antidotes, snake anti-venom
and medicines used in the management of chronic kid-
ney disease. However availability of anti-hypertensive
medicines, anti-diabetics and diuretics was commend-
able yet there is room for improvement. This will reduce
not only the overcrowding at tertiary care institutions
but also the indirect health care cost for rural residents.
Amalgamating the concept based “essential medicines”
with the need based “annual estimates” is suggested for
improving the availability of essential medicines.
Additional file
Additional file 1: Availability of essential medicines in a rural Sri Lankan
district, 2016. This provides the results of the entire survey with data for
each essential medicine. (XLS 187 kb)
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